Semaglutide
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
Semaglutide
Semaglutide (SEMA)

Semaglutide (SEMA) is a synthetic 31-residue GLP-1 analogue and glucagon-like peptide-1 receptor (GLP-1R) agonist supplied for laboratory research.(SM5,SEMA,SEM)
Overview
Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue with two amino acid substitutions relative to human GLP-1 (Aib8, Arg34) and a fatty-acid derivatization at lysine 26. It is used as a single-receptor GLP-1R reference peptide in laboratory research.
Peptides Duo supplies semaglutide with full analytical documentation, scalable quantities and dependable worldwide delivery.
What is Semaglutide?
Semaglutide is a polypeptide of 31 amino acids joined by peptide linkages. It shares 94% sequence homology with native human GLP-1 and is classified as a glucagon-like peptide-1 receptor agonist. The backbone follows GLP-1(7–37) numbering and is supplied as a reference compound for receptor and analytical peptide research.
Sequence and modifications
Relative to native GLP-1, semaglutide carries three designed changes: Ala8 is replaced by α-aminoisobutyric acid (Aib), Lys34 is replaced by arginine, and Lys26 is acylated through a spacer of two 8-amino-3,6-dioxaoctanoic acid (ADO) units and a γ-glutamate linker to a C18 fatty diacid. Backbone (GLP-1 7–37 numbering): H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(C18 diacid–γGlu–ADO–ADO)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH.
Key Highlights
- GLP-1 receptor agonist (GLP-1R); single-receptor incretin analogue
- 31-residue backbone; Aib8, Arg34; Lys26 C18 fatty-diacid acylation
- ≥99% purity verified by HPLC & Mass Spectrometry
- Lyophilized solid peptide, good stability
- Full batch-to-batch traceability, COA available for every lot
- Third-party tested, research-grade raw material
Safety & Side Effects
Semaglutide (SEMA) is a synthetic 31-residue GLP-1 analogue and glucagon-like peptide-1 receptor (GLP-1R) agonist supplied for laboratory research.(SM5,SEMA,SEM) When used in research, Semaglutide should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.
Published semaglutide side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for metabolic regulation and energy expenditure readouts and any off-target effects relevant to the compound’s mechanism when designing a study.
For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.
Dosage & Protocol
There is no standardized human dosage for Semaglutide; it is supplied strictly for laboratory research. Reported semaglutide dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.
Research protocols typically document semaglutide dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 910463-68-2, molecular formula C187H291N45O59, molecular weight 4113.6 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.
Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.
Comparison
| Peptide | Receptors | Core Characteristic |
|---|---|---|
| Semaglutide | GLP-1R | Single GLP-1 receptor agonist |
| Tirzepatide | GLP-1R + GIPR | Dual-receptor metabolic peptide |
| Retatrutide | GLP-1R + GIPR + GCGR | Triple agonist for metabolic research |
How to Order
Enquiry
Send strength and quantity for a quote.
Quotation
Price, lead time and specification confirmed.
QC & COA
HPLC/LC-MS tested; COA issued.
Delivery
Tracked worldwide shipping.
Specifications
| Product name | Semaglutide |
|---|---|
| Product code | SM5 |
| Specification | 5mg*10vials |
| CAS number | 910463-68-2 |
| Molecular formula | C187H291N45O59 |
| Molecular weight | 4113.6 g/mol |
| Purity | ≥99% (subject to batch COA) |
| Physical Form | Lyophilized white solid powder |
| Solubility | Soluble in bacteriostatic water |
| Amino Acid Count | 31 residues |
Applications
Packaging & Shipping
Available pack sizes
Shipping
Storage & Handling
Store lyophilized at −20°C, protected from light and moisture. Bring to room temperature before opening. Refrigerate after reconstitution and avoid repeated freeze-thaw cycles.
Product Information Q&A
Is Semaglutide third-party tested?
Yes, every batch is third-party tested for purity verification.
Can I view the Certificate of Analysis before purchase?
Corresponding batch COA documents are available upon request.
What does “Research Use Only” mean?
This peptide is for laboratory research only, not for human or veterinary administration.
How should Semaglutide be shipped and stored?
Shipped as lyophilized powder. Store dry powder at −20°C away from light and humidity.
How does Semaglutide differ from tirzepatide and retatrutide?
Semaglutide is a GLP-1R agonist. Tirzepatide engages GLP-1R and GIPR. Retatrutide engages GLP-1R, GIPR and GCGR. Receptor profiles are listed for research comparison only.
Additional information
| Specification | 5mg*10vials, 10mg*10vials, 15mg*10vials, 20mg*10vials, 30mg*10vials |
|---|




